Join the BioNap Email List!

Wednesday, July 29, 2015

Neuralstem Wins Patent Infringement Case Vs. StemCell, Inc.; Moves Forward In Spinal Cord Injury

By Jason Napodano, CFA

- Neuralstem won its long-standing patent infringement case vs. StemCells, Inc.

- Work continues with NSI-566 in both ALS and SCI.
- Anecdotal evidence from one patient in the Phase 1 spinal cord injury trial is encouraging.
- I believe the shares are worth $3.50.
Please read the article on Seeking-Alpha: LINK

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.